首页> 外文期刊>Nanomaterials >Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam 1 CSK 4 and Pam 3 CSK 4
【24h】

Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam 1 CSK 4 and Pam 3 CSK 4

机译:聚(乳酸)纳米粒子的分子动力学研究及其与维生素E和TLR激动剂的相互作用PAM 1 CSK 4和PAM 3 CSK 4

获取原文
       

摘要

Poly(lactic acid) (PLA) nanoparticles (NPs) are widely investigated due to their bioresorbable, biocompatible and low immunogen properties. Interestingly, many recent studies show that they can be efficiently used as drug delivery systems or as adjuvants to enhance vaccine efficacy. Our work focuses on the molecular mechanisms involved during the nanoprecipitation of PLA NPs from concentrated solutions of lactic acid polymeric chains, and their specific interactions with biologically relevant molecules. In this study, we evaluated the ability of a PLA-based nanoparticle drug carrier to vectorize either vitamin E or the Toll-like receptor (TLR) agonists Pam 1 CSK 4 and Pam 3 CSK 4 , which are potent activators of the proinflammatory transcription factor NF-κB. We used dissipative particle dynamics (DPD) to simulate large systems mimicking the nanoprecipitation process for a complete NP. Our results evidenced that after the NP formation, Pam 1 CSK 4 and Pam 3 CSK 4 molecules end up located on the surface of the particle, interacting with the PLA chains via their fatty acid chains, whereas vitamin E molecules are buried deeper in the core of the particle. Our results allow for a better understanding of the molecular mechanisms responsible for the formation of the PLA NPs and their interactions with biological molecules located either on their surfaces or encapsulated within them. This work should allow for a rapid development of better biodegradable and safe vectorization systems with new drugs in the near future.
机译:由于其生物可吸收,生物相容性和低免疫原性,广泛研究了聚(乳酸)(PLA)纳米颗粒(NPS)。有趣的是,许多最近的研究表明,它们可以有效地用作药物递送系统或辅助剂以增强疫苗疗效。我们的作品侧重于从乳酸聚合物链的浓缩溶液的PLA NPS纳米尺寸期间参与的分子机制及其与生物相关分子的特异性相互作用。在本研究中,我们评估了基于PLA的纳米粒子药物载体的能力,所述纳米粒子药物载体向载体化的维生素E或TLR样受体(TLR)激动剂PAM1 CSK 4和PAM 3 CSK 4,其是促炎性转录因子的有效活化剂NF-κB。我们使用耗散粒子动力学(DPD)来模拟模拟纳米沉淀过程的大型系统,以实现完整的NP。我们的结果证明,在NP形成之后,PAM 1 CSK 4和PAM 3 CSK 4分子位于颗粒表面上,通过其脂肪酸链与PLA链相互作用,而维生素E分子在芯中深入埋入核心颗粒。我们的结果允许更好地理解负责形成PLA NP的分子机制及其与位于其表面上的生物分子的相互作用或封装在它们内。这项工作应允许在不久的将来快速发展具有新药的更好的可生物降解和安全的矢量化系统。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号